AMETEK, Inc. (AME), a Berwyn, Pennsylvania-based maker of electronic instruments and electromechanical devices, is a stock rather than an exchange-traded fund. Its analyst coverage is extensive and generally constructive, though not unanimous.
Reviewing current, attributable targets yields a cluster between roughly $255 and $316, with an arithmetic mean near $284 and a rounded central target of $285. Recent revisions include RBC Capital at $291 (October 2026), Citi at $263, Morgan Stanley at $275, Baird at $280, Bank of America at $300, Truist at $316, KeyBanc at $295, Seaport Research at $290, and Mizuho and DA Davidson at $285. Several aggregators report a wider spread that includes a low outlier near $230, underscoring how dispersed the "analyst consensus" is despite an overall Buy/Moderate Buy rating.
Bullish analysts emphasize durable earnings growth and capital deployment, while more cautious voices, concentrated at Citi, Morgan Stanley, and Baird, argue the shares already reflect much of that quality. No single target should be read as a guarantee.
AME recently closed near $241, down from a 52-week high of roughly $261 set in August 2026. From that level, the $285 central target implies about 18% upside—a substantial move by ordinary standards. The path would likely require continued execution on the company's growth algorithm, favorable order trends across its electronic instruments and electromechanical segments, and either sustained earnings expansion or a market willing to hold an elevated multiple.
Valuation is a key variable. The stock trades near 27–28 times forward earnings, a premium to many diversified industrials, meaning multiple expansion alone is unlikely to carry it to $285; earnings growth would need to do much of the work.
The August high near $261 is the most relevant resistance zone; a sustained push toward $285 would first require clearing that level. Psychological resistance sits near $250–$260. On the downside, recent lows around $235–$240 mark near-term support, with the 52-week low near $183 a more durable floor. The stock's pullback from its peak, while notable, has not broken its longer-term uptrend structure.
Most analyst price targets reflect a forward research horizon of roughly 12 months, though individual analysts differ in methodology and timing. The near-term catalyst is the third-quarter report scheduled before the market opens on November 3, 2026, when investors will weigh results against guidance of $2.08–$2.10 in adjusted EPS. Beyond earnings, watch analyst target revisions, order and backlog trends, acquisition integration, tariff developments, and broader industrial-demand data. None of these provides a definitive timetable for the $285 figure.
For traders seeking a real-time complement to fundamental research, Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from evolving market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual scanning. As AME navigates its earnings catalyst and key technical levels, automated signal monitoring can provide an additional layer of market awareness alongside traditional research.
The question of whether AMETEK can reach $285 comes down to execution and valuation, not a single catalyst. The central target—the rounded mean of roughly a dozen current analyst price targets—represents about 18% upside from recent levels, a substantial move that would require sustained earnings growth rather than multiple expansion alone. Strong guidance, a recent beat, and an acquisitive growth strategy support the case, while a premium valuation, tariff uncertainty, and cyclical demand risk remain the principal obstacles. With targets spanning roughly $255 to $316, analyst disagreement is meaningful and the mean should be viewed as a reference point, not a prediction. Investors should watch the upcoming earnings report and subsequent analyst revisions closely.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, AME has been closely correlated with ROP. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if AME jumps, then ROP could also see price increases.
| Ticker / NAME | Correlation To AME | 1D Price Change % |
|---|---|---|
| AME | 100% | +0.33% |
| AME (2 stocks) | 94% Closely correlated | +1.54% |
| Producer Manufacturing (348 stocks) | 15% Poorly correlated | +1.00% |